Literature DB >> 19724997

[Antipsychotic treatment of dementia after publication of new risks].

Markus Wittmann1, Helmut Hausner, Göran Hajak, Ekkehard Haen.   

Abstract

OBJECTIVE: We investigated the change of antipsychotic treatment of elderly persons with dementia after several publications indicated an association between use of antipsychotics and cerebrovascular events in this population.
METHODS: Twice a year, the complete medication, age, diagnosis and gender of all inpatients in 30 German psychiatric sites is collected anonymously in a data base for statistical analysis.
RESULTS: The treatment changed for the benefit of Quetiapine and Haloperidol. The use of both Risperidone and Olanzapine decreased markedly.
CONCLUSION: The antipsychotic treatment changed due to critical publication. But, the evidence for the risk profile is still a matter of debate.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19724997     DOI: 10.1055/s-0029-1220368

Source DB:  PubMed          Journal:  Psychiatr Prax        ISSN: 0303-4259


  1 in total

1.  [Antipsychotics for treatment of neuropsychiatric disorders in dementia].

Authors:  H-J Gertz; G Stoppe; B Müller-Oerlinghausen; L G Schmidt; C Baethge; C Hiemke; K Lieb; T Bschor
Journal:  Nervenarzt       Date:  2013-03       Impact factor: 1.214

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.